MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 1 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $110,000 | -1.8% | 2,200 | 0.0% | 0.04% | +10.3% |
Q1 2022 | $112,000 | -48.9% | 2,200 | -38.9% | 0.04% | -47.3% |
Q4 2021 | $219,000 | +8.4% | 3,600 | -14.3% | 0.07% | +1.4% |
Q3 2021 | $202,000 | -8.6% | 4,200 | 0.0% | 0.07% | -11.0% |
Q2 2021 | $221,000 | +6.2% | 4,200 | 0.0% | 0.08% | 0.0% |
Q1 2021 | $208,000 | +2.0% | 4,200 | 0.0% | 0.08% | -6.8% |
Q4 2020 | $204,000 | -3.3% | 4,200 | 0.0% | 0.09% | -14.6% |
Q3 2020 | $211,000 | -1.4% | 4,200 | 0.0% | 0.10% | -8.0% |
Q2 2020 | $214,000 | +16.3% | 4,200 | 0.0% | 0.11% | +3.7% |
Q1 2020 | $184,000 | -12.8% | 4,200 | 0.0% | 0.11% | +9.1% |
Q4 2019 | $211,000 | +8.2% | 4,200 | 0.0% | 0.10% | 0.0% |
Q3 2019 | $195,000 | +7.1% | 4,200 | 0.0% | 0.10% | +5.3% |
Q2 2019 | $182,000 | -2.2% | 4,200 | 0.0% | 0.09% | -6.9% |
Q1 2019 | $186,000 | +2.2% | 4,200 | 0.0% | 0.10% | -10.6% |
Q4 2018 | $182,000 | -3.2% | 4,200 | 0.0% | 0.11% | +3.7% |
Q3 2018 | $188,000 | +11.9% | 4,200 | 0.0% | 0.11% | +4.8% |
Q2 2018 | $168,000 | 0.0% | 4,200 | 0.0% | 0.10% | +1.0% |
Q1 2018 | $168,000 | -7.2% | 4,200 | 0.0% | 0.10% | -7.2% |
Q4 2017 | $181,000 | -15.0% | 4,200 | -1.8% | 0.11% | -19.0% |
Q3 2017 | $213,000 | +12.1% | 4,276 | +7.5% | 0.14% | +6.2% |
Q2 2017 | $190,000 | +5.6% | 3,976 | 0.0% | 0.13% | 0.0% |
Q1 2017 | $180,000 | +11.8% | 3,976 | 0.0% | 0.13% | +4.0% |
Q4 2016 | $161,000 | – | 3,976 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|